pharma operations – Page 30

Transport qualification gaps during storage – how to prevent repeat excursions

Addressing Transport Qualification Gaps During Storage to Prevent Future Excursions Transport qualification gaps can lead to significant challenges in pharmaceutical manufacturing. For companies operating in regulated environments, understanding and addressing…

User account governance failures during system operation – CAPA and revalidation strategy

User Account Governance Failures During System Operation: Investigation and Remediation Strategies User account governance is a critical component of regulated pharmaceutical environments, particularly where system access and data integrity are…

Distribution temperature breach during storage – product quality risk assessment

Evaluating the Risks of Distribution Temperature Breaches During Storage Temperature control is critical in pharmaceutical manufacturing and distribution, as breaches can compromise product quality and safety. This article provides a…

Interface validation gaps during system operation – FDA/EMA expectations for computerized systems

Addressing Gaps in Interface Validation During System Operation: A Practical Investigation Approach In today’s highly regulated pharmaceutical environment, computerized systems play a pivotal role in ensuring compliance and operational efficiency.…

Excursion trend ignored during transportation – product quality risk assessment

Assessing the Risks of Ignored Excursion Trends During Pharmaceutical Transport In the highly regulated pharmaceutical environment, anticipating and managing risks during product transportation is critical to maintaining quality. An ignored…

Data backup and restore failure during validation lifecycle – CAPA and revalidation strategy

Investigating Data Backup and Restore Failures Throughout the Validation Lifecycle Data integrity and lifecycle management are critical components of pharmaceutical manufacturing and quality control. When data backup and restore failures…

Excursion trend ignored during audit – product quality risk assessment

“`html Investigating Ignored Excursion Trends During Audits: A Risk to Product Quality In pharmaceutical manufacturing, the integrity of data signals is paramount to maintaining compliance and ensuring product quality. One…

User account governance failures during system upgrades – CAPA and revalidation strategy

Addressing User Account Governance Issues During System Upgrades: CAPA and Revalidation Strategies The pharmaceutical manufacturing landscape is continuously evolving, particularly with the integration of advanced IT systems. A common challenge…

Cold chain excursion not assessed during storage – regulatory inspection outcome

Assessing Cold Chain Excursions During Storage: A Regulatory Investigation Framework In the pharmaceutical industry, ensuring the integrity of temperature-sensitive materials during storage is paramount. A cold chain excursion not assessed…

Interface validation gaps during inspection walkthrough – data integrity risk and remediation

Investigating Interface Validation Gaps During Inspection Walkthroughs for Data Integrity Risks In the fast-evolving landscape of pharmaceutical operations, interface validation gaps present significant vulnerabilities during regulatory inspections. With authorities like…

Distribution temperature breach during transportation – regulatory inspection outcome

Examining Distribution Temperature Breaches in Pharmaceutical Transportation: An Investigation Framework Distribution temperature breaches during transportation pose significant risks to pharmaceutical products, jeopardizing compliance with Good Manufacturing Practices (GMP) and resulting…

Data backup and restore failure during validation lifecycle – FDA/EMA expectations for computerized systems

Understanding Data Backup and Restore Failures During Validation Lifecycle in Pharma Data backup and restore failures in computerized systems pose significant challenges to pharmaceutical manufacturers, particularly during the validation lifecycle.…